Content from L.S. Howard
Reinsurers’ Investment Strategies Help Them Tolerate COVID-19 Impact: S&P
A decade of low interest rates and tough underwriting conditions has led reinsurers to cautiously invest in riskier and more illiquid assets to generate additional return. The good news is that this ...
With Tech Tools Galore, It’s an Exciting Time for InsurTech McKenzie Intelligence
Advanced technological tools are making it an exciting time to be an InsurTech – and an exciting time for those insurers and reinsurers that want to more accurately assess the risks on their books, ...
The Digital Normal and the Future of Work in Reinsurance
It's been said that necessity is the mother of invention. That proverb was illustrated perfectly during the insurance industry's successful scramble to conduct its business digitally at the onset of ...
COVID-19 Crisis Renews Attention on Systemic (Uninsurable) Risks
Reinsurers and insurers for years have been worried about systemic risks – those uninsurable risks with the potential of surpassing the capital of the industry. The COVID-19 crisis has renewed ...
Reinsurance Demand Rises, Along with Flight to Quality, Say Industry Experts
Not only has reinsurance buying increased, but there also has been a flight to quality reinsurers by ceding insurance companies, according to several reinsurers and brokers in recent webinars held in ...
Catastrophe Losses Driven Higher by Secondary Perils – And Climate Change
Secondary perils, exacerbated by climate change, are driving catastrophe insurance losses, warn a growing chorus of reinsurers and brokers. Indeed, broker Aon reveals that more than 60% of 2020's ...
Independent Brokers Will Remain Competitive by Adding Value to the Insurance Transaction
The COVID-19 crisis has highlighted the need for brokers to add value to the insurance transaction, according to Toby Esser, chairman of AFL Insurance Brokers, a London-based independent broker. ...
How Insurance Industry Might Respond if a Pandemic Is an Act of Terror
Imagine a scenario where COVID-19 was manufactured in a lab and was released as an act of terror. Tracey Gibbons, senior vice present, Underwriting, at Third Point Re, considers this possibility ...

